T1	Participants 87 146	patients with metabolic syndrome receiving low-dose aspirin
T2	Participants 553 724	Patients who had metabolic syndrome were randomized to receive clopidogrel 75 mg/day plus aspirin 81 mg/day (n = 89) or placebo plus aspirin 81 mg/day (n = 92) for 9 weeks
